~~<i id='1CDC306E1D'><strike id='1CDC306E1D'><tt id='1CDC306E1D'><pre id='1CDC306E1D'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

author：leisure time 2025-10-02 15:35:18 Page View：8

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo
Next article： Hollywood unions extend contract negotiations for actors

explore

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

5 dead in mass shooting on Caribbean island of St. Vincent: Police

1:27Catchuponthedevelopingstoriesfromaroundtheglobemakingheadlines.STOCKPHOTO/GettyImagesPORTOFSPAIN

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

There’s a way to spot data fakery. All journals should be using it

STAT,APStockAstheBritishpoliticianBenjaminDisraelifamouslyobserved,therearelies,damnlies,andstatisti